Although the association between Peyronie’s disease (PD) and erectile dysfunction (ED) is well established, limited data are available correlating penile curvature and penile hemodynamic parameters. We sought to examine this association in a cohort of PD men undergoing penile duplex Doppler ultrasound (PDDU). PD patients were retrospectively evaluated to correlate the extent and direction of penile curvature with measured vascular parameters. Demographic variables, disease characteristics and PDDU parameters were tabulated and statistically compared based on extent (≤45° and >45°) and direction (dorsal, ventral, lateral, ventrolateral, dorsolateral) of curvature. A total of 220 PD patients (mean age of 55.0±9.2 years) underwent PDDU at one institution from January 2008 to December 2010. Overall, 69.5% of patients were found to have vasculogenic ED (arterial insufficiency (AI): 10%; veno-occlusive dysfunction (VOD): 43.2%; AI+VOD: 16.4%). Mean curvature was similar among all PDDU groups (AI: 41.7±5.2°; VOD: 41.3±2.5°; AI+VOD: 37±4.1°; no-ED: 37.3±3°; P>0.85). No significant differences were noted in the presence or type of ED among various directions of curvature (P=0.34) or when curvatures were stratified by ≤45° and >45°. The direction and extent of penile curvature are not associated with altered rates of vasculogenic ED on PDDU in PD patients.
This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $14.88 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
La Pera G, Pescatori ES, Calabrese M, Boffini A, Colombo F, Andriani E et al. Peyronie’s disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50-69 years. Eur Urol 2001; 40: 525–530.
Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A et al. Subjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screening. J Urol 2004; 171 (6 Pt 1): 2350–2353.
Schwarzer U, Sommer F, Klotz T, Braun M, Reifenrath B, Engelmann U . The prevalence of Peyronie’s disease: results of a large survey. BJU Int 2001; 88: 727–730.
Smith JF, Walsh TJ, Lue TF . Peyronie’s disease: a critical appraisal of current diagnosis and treatment. Int J Impot Res 2008; 20: 445–459.
Ralph D, Gonzalez-Cadavid N, Mirone V, Perovic S, Sohn M, Usta M et al. The management of Peyronie’s disease: evidence-based 2010 guidelines. J Sex Med 2010; 7: 2359–2374.
Chung E, De Young L, Brock GB . Penile duplex ultrasonography in men with Peyronie’s disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction? J Sex Med 2011; 8: 3446–3451.
Gelbard MK, Dorey F, James K . The natural history of Peyronie’s disease. J Urol 1990; 144: 1376–1379.
Kadioglu A, Tefekli A, Erol B, Oktar T, Tunc M, Tellaloglu S . A retrospective review of 307 men with Peyronie’s disease. J Urol 2002; 168: 1075–1079.
Mulhall JP, Schiff J, Guhring P . An analysis of the natural history of Peyronie’s disease. J Urol 2006; 175: 2115–2118, discussion 2118.
Amin Z, Patel U, Friedman EP, Vale JA, Kirby R, Lees WR . Colour Doppler and duplex ultrasound assessment of Peyronie’s disease in impotent men. Br J Radiol 1993; 66: 398–402.
Kadioglu A, Oktar T, Kandirali E, Kendirci M, Sanli O, Ozsoy C . Incidentally diagnosed Peyronie’s disease in men presenting with erectile dysfunction. Int J Impot Res 2004; 16: 540–543.
Grasso M, Lania C, Blanco S, Limonta G . The natural history of Peyronie’s disease. Arch Esp Urol 2007; 60: 326–331.
Lindsay MB, Schain DM, Grambsch P, Benson RC, Beard CM, Kurland LT . The incidence of Peyronie’s disease in Rochester, Minnesota, 1950 through 1984. J Urol 1991; 146: 1007–1009.
Gonzalez-Cadavid NF . Mechanisms of penile fibrosis. J Sex Med 2009; 6 (Suppl 3): 353–362.
Bekos A, Arvaniti M, Hatzimouratidis K, Moysidis K, Tzortzis V, Hatzichristou D . The natural history of Peyronie's disease: an ultrasonography-based study. Eur Urol 2008; 53: 644–650.
Walsh TJ, Hotaling JM, Lue TF, Smith JF . How curved is too curved? The severity of penile deformity may predict sexual disability among men with Peyronie's disease. Int J Impot Res 2013; 25: 109–112.
Garaffa G, Trost LW, Serefoglu EC, Ralph D, Hellstrom WJ . Understanding the course of Peyronie’s disease. Int J Clin Pract 2013; 67: 781–788.
Mulhall J, Anderson M, Parker M . A surgical algorithm for men with combined Peyronie’s disease and erectile dysfunction: functional and satisfaction outcomes. J Sex Med 2005; 2: 132–138.
Serefoglu EC, Hellstrom WJ . Treatment of Peyronie’s disease: 2012 update. Curr Urol Rep 2011; 12: 444–452.
Lee B, Sikka SC, Randrup ER, Villemarette P, Baum N, Hower JF et al. Standardization of penile blood flow parameters in normal men using intracavernous prostaglandin E1 and visual sexual stimulation. J Urol 1993; 149: 49–52.
Kendirci M, Usta MF, Matern RV, Nowfar S, Sikka SC, Hellstrom WJ . The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease. J Sex Med 2005; 2: 709–715.
Montorsi F, Guazzoni G, Bergamaschi F, Consonni P, Rigatti P, Pizzini G et al. Vascular abnormalities in Peyronie’s disease: the role of color Doppler sonography. J Urol 1994; 151: 373–375.
Dibenedetti DB, Nguyen D, Zografos L, Ziemiecki R, Zhou X . A population-based study of Peyronie’s disease: prevalence and treatment patterns in the United States. Adv Urol 2011; 2011: 282503.
Hellstrom WJ . Medical management of Peyronie’s disease. J Androl 2009; 30: 397–405.
Chung E, Yan H, De Young L, Brock GB . Penile Doppler sonographic and clinical characteristics in Peyronie’s disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunction. BJU Int 2012; 110: 1201–1205.
Kadioglu A, Tefekli A, Erol H, Cayan S, Kandirali E . Color Doppler ultrasound assessment of penile vascular system in men with Peyronie’s disease. Int J Impot Res 2000; 12: 263–267.
Bella AJ, Sener A, Foell K, Brock GB . Nonpalpable scarring of the penile septum as a cause of erectile dysfunction: an atypical form of Peyronie’s disease. J Sex Med 2007; 4: 226–230.
Smith JF, Brant WO, Fradet V, Shindel AW, Vittinghoff E, Chi T et al. Penile sonographic and clinical characteristics in men with Peyronie’s disease. J Sex Med 2009; 6: 2858–2867.
Breyer BN, Shindel AW, Huang YC, Eisenberg ML, Weiss DA, Lue TF et al. Are sonographic characteristics associated with progression to surgery in men with Peyronie’s disease? J Urol 2010; 183: 1484–1488.
Deveci S, Palese M, Parker M, Guhring P, Mulhall JP . Erectile function profiles in men with Peyronie’s disease. J Urol 2006; 175: 1807–1811, discussion 1811.
Usta MF, Bivalacqua TJ, Jabren GW, Myers L, Sanabria J, Sikka SC et al. Relationship between the severity of penile curvature and the presence of comorbidities in men with Peyronie’s disease. J Urol 2004; 171 (2 Pt 1): 775–779.
Usta MF, Bivalacqua TJ, Tokatli Z, Rivera F, Gulkesen KH, Sikka SC et al. Stratification of penile vascular pathologies in patients with Peyronie’s disease and in men with erectile dysfunction according to age: a comparative study. J Urol 2004; 172: 259–262.
Kendirci M, Nowfar S, Gur S, Jabren GW, Sikka SC, Hellstrom WJ . The relationship between the type of penile abnormality and penile vascular status in patients with Peyronie’s disease. J Urol 2005; 174: 632–635, discussion 635.
The authors declare no conflict of interest.
About this article
Cite this article
Serefoglu, E., Trost, L., Sikka, S. et al. The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie’s disease. Int J Impot Res 27, 6–8 (2015). https://doi.org/10.1038/ijir.2014.25
This article is cited by
International Journal of Impotence Research (2022)